glp-1 and gout GLP-1s may increase risk of osteoporosis gout, new research finds Glucagon-like peptide 1(GLP-1) receptor agonists

Only a small number of people need to stop treatment because of side effects

How to Prevent Muscle Loss When Using Ozempic and Other GLP-1s How to Prevent Muscle Loss When Using a GLP-1 GLP-1 agonist medications (Ozempic and Wegovy) and dual GIP/GLP-1 receptor agonist medications (Zepbound and Mounjoaro) are powerful tools for weight loss, but losing weight rapidly can also lead the body to lose too much muscle mass

These drugs effectively lower blood glucose levels and provide cardiovascular and renal benefits, making them a preferred treatment option in diabetes care

Until then, experts said its important to remember that research around microdosing is limited, and should only be done under the recommendation and guidance of a healthcare professional

Not based on current data

Over-the-counter remedies may offer temporary relief